Page 4 - Nasdaq Podd News Today

Insulet Co. (NASDAQ:PODD – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eighteen research firms that are covering the company, Marketbeat reports. Six analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average twelve-month price target among brokers […]

Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its stake in Insulet Co. (NASDAQ:PODD – Free Report) by 6.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 9,900 shares of the medical instruments supplier’s stock after acquiring an additional 600 shares during the […]

Oppenheimer Asset Management Inc. decreased its holdings in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 1.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,229 shares of the medical instruments supplier’s stock after selling 342 shares during the quarter. […]

Shares of Insulet Co. (NASDAQ:PODD – Get Free Report) traded down 3.1% on Tuesday . The company traded as low as $142.21 and last traded at $142.38. 313,121 shares were traded during mid-day trading, a decline of 65% from the average session volume of 884,370 shares. The stock had previously closed at $147.00. Wall Street […]

SVB Leerink assumed coverage on shares of Insulet (NASDAQ:PODD – Free Report) in a report released on Monday, Benzinga reports. The firm issued an outperform rating and a $184.00 price objective on the medical instruments supplier’s stock. PODD has been the topic of several other research reports. Raymond James cut their target price on Insulet […]

Leerink Partnrs reissued their outperform rating on shares of Insulet (NASDAQ:PODD – Free Report) in a research note published on Monday, PriceTargets.com reports. Leerink Partnrs also issued estimates for Insulet’s Q3 2023 earnings at $0.44 EPS, Q4 2023 earnings at $0.68 EPS, Q1 2024 earnings at $0.48 EPS, Q2 2024 earnings at $0.69 EPS, Q3 […]

Insulet Co. (NASDAQ:PODD – Get Free Report) saw a large growth in short interest during the month of September. As of September 30th, there was short interest totalling 3,570,000 shares, a growth of 24.0% from the September 15th total of 2,880,000 shares. Based on an average daily volume of 1,150,000 shares, the days-to-cover ratio is […]

EFG Asset Management North America Corp. raised its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 14.7% in the second quarter, HoldingsChannel.com reports. The firm owned 15,590 shares of the medical instruments supplier’s stock after purchasing an additional 1,995 shares during the quarter. EFG Asset Management North America Corp.’s holdings in Insulet were worth […]

Congress Asset Management Co. MA lifted its stake in Insulet Co. (NASDAQ:PODD – Free Report) by 7.0% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 13,029 shares of the medical instruments supplier’s stock after acquiring an additional 851 shares during the period. Congress Asset Management Co. MA’s holdings in Insulet were worth $3,757,000 as […]

Congress Asset Management Co. MA lifted its stake in Insulet Co. (NASDAQ:PODD – Free Report) by 7.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 13,029 shares of the medical instruments supplier’s stock after acquiring an additional 851 shares during the quarter. […]